April 25 - 26, 2024

at the Sheraton New York Times Square Hotel, New York, NY, USA

Booth #18

Visit us at Booth #18 and check out the additional activities below.

Jump to a section to learn more:

Podium Presentation

This year, AATS Aortic Symposium has put together a top-notch scientific program. Be sure to check out some of the key sessions we found interesting. Remember that you must be registered with the meeting to attend any sessions.


Thursday, April 25th | 10:00 AM ET

Bentall Procedure; A Long-term, Single Center Experience

Speaker:

Davide Pacini, MD
University of Bologna

Thursday, April 25th | 2:19 PM ET

The Ross Procedure: Indications in the Modern Era

Speaker:

Ismail El-Hamamsy, MD
Mount Sinai Hospital

Poster Presentations


Thursday, April 25th | 5:38 PM ET

Do Collagen Impregnated Frozen Elephant Trunk Stent Grafts Bleed Less Than Non-Collagen Impregnated Grafts?

Speaker:

Ravi De Silva, Royal Papworth Hospital

Thursday, April 25th | 5:38 PM ET

A Multi-centre Study of Short and Mid-term Outcomes of the Ascyrus Medical Dissection Stent (AMDS) in the Treatment of Acute Type A Aortic Dissection

Speaker:

Stuart Grant

Thursday, April 25th | 5:38 PM ET

Use of AMDS in DeBakey Type I Aortic Dissection - A retrospective analysis of a single centre data & propensity match comparative analysis with Ascending Aorta Replacement

Speaker:

Ruhina Alam, Royal Papworth Hospital

Ongoing Clinical Trials

Stop by our booth to learn more.


PERSEVERE Pivotal IDE Study

A ProspEctive, Single ARm, Multi-Center Clinical InveStigation to EValuatE the Safety and Effectiveness of AMDS* in the TREatment of Acute DeBakey Type I Dissection Pivotal IDE Study. AMDS is intended for aortic repair, aortic remodeling, and re-expansion of the intimal flap within the ascending aorta, aortic arch, and into the descending aorta for patients with acute DeBakey I aortic dissection undergoing open surgical repair within 0 to 14 days after diagnosis.

Triomphe Pivotal IDE Study

  Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUS) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
Caution: AMDS and NEXUS are investigational devices. Limited by Federal (or United States) law to investigational use. All products and indications are not available/approved in all markets. Please contact your local Artivion representative for details.